GB1479496A - Antibiotic compositions - Google Patents
Antibiotic compositionsInfo
- Publication number
- GB1479496A GB1479496A GB6613/75A GB661375A GB1479496A GB 1479496 A GB1479496 A GB 1479496A GB 6613/75 A GB6613/75 A GB 6613/75A GB 661375 A GB661375 A GB 661375A GB 1479496 A GB1479496 A GB 1479496A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ruminants
- lactic acidosis
- antibiotics
- feb
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000282849 Ruminantia Species 0.000 abstract 5
- 208000006443 lactic acidosis Diseases 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- -1 theiomycetin Chemical compound 0.000 abstract 2
- SFWLDKQAUHFCBS-AOEYGKNYSA-N (1S,4S,13S,16S,19S,22S,25S,28R,31S,37S,40S,41S,44R,47S,50S,53S,56R,65S,70S)-44-amino-47-(4-aminobutyl)-4,16,22-tribenzyl-31-[(R)-carboxy(hydroxy)methyl]-2,5,14,17,20,23,26,29,32,35,38,45,48,51,54,57,67-heptadecahydroxy-37-(2-hydroxy-2-iminoethyl)-50-(3-hydroxy-3-iminopropyl)-41,70-dimethyl-8-oxo-25-propan-2-yl-42,69,72-trithia-3,6,9,15,18,21,24,27,30,33,36,39,46,49,52,55,58,60,66-nonadecazapentacyclo[38.18.9.319,56.328,53.09,13]triheptaconta-2,5,14,17,20,23,26,29,32,35,38,45,48,51,54,57,66-heptadecaene-65-carboxylic acid Chemical compound CC(C)[C@@H]1\N=C(O)/[C@H](Cc2ccccc2)\N=C(O)/[C@@H]2\N=C(O)/[C@H](Cc3ccccc3)\N=C(O)/[C@@H]3CCCN3C(=O)C\N=C(O)/[C@H](Cc3ccccc3)\N=C(O)/[C@@H]3CNCCCC[C@H](\N=C(O)\[C@@H]4\N=C(O)\[C@H](CC(O)=N)\N=C(O)\C\N=C(O)/[C@@H](\N=C(O)\[C@H](CSC[C@@H](N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](CCCCN)N=C(O)[C@@H](N)CS[C@H]4C)C(O)=N[C@@H](CS[C@H]2C)C(O)=N3)\N=C1\O)[C@@H](O)C(O)=O)C(O)=O SFWLDKQAUHFCBS-AOEYGKNYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- FPTCMHOCGKKRGQ-WYOWUDGCSA-N Multhiomycin Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)c3cc(O)c(nc3c4csc(n4)[C@H]5CSC(=O)c6[nH]c7cccc(COC(=O)[C@@H](O)C[C@H](NC(=O)c8csc1n8)c9nc(cs9)C(=O)N5)c7c6C)c%10nc(cs%10)C(=O)N[C@@H](C)C(=O)N)[C@H](C)O FPTCMHOCGKKRGQ-WYOWUDGCSA-N 0.000 abstract 1
- OQAOHXRUMXWDLQ-ATVZKCIHSA-N N-(3-amino-3-oxoprop-1-en-2-yl)-2-[(1S,18S,21Z,28S,30S)-21-ethylidene-9,30-dihydroxy-18-[(1R)-1-hydroxyethyl]-40-methyl-16,19,26,31,42,46-hexaoxo-32-oxa-3,13,23,43,49-pentathia-7,17,20,27,45,51,52,53,54,55-decazanonacyclo[26.16.6.12,5.112,15.122,25.138,41.147,50.06,11.034,39]pentapentaconta-2(55),4,6,8,10,12(54),14,22(53),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-1,3-thiazole-4-carboxamide Chemical compound C\C=C1/NC(=O)[C@@H](NC(=O)c2csc(n2)-c2cc(O)c(nc2-c2csc(n2)[C@@H]2CSC(=O)c3[nH]c4cccc(COC(=O)[C@@H](O)C[C@H](NC(=O)c5csc1n5)c1nc(cs1)C(=O)N2)c4c3C)-c1nc(cs1)C(=O)NC(=C)C(N)=O)[C@@H](C)O OQAOHXRUMXWDLQ-ATVZKCIHSA-N 0.000 abstract 1
- AKFVOKPQHFBYCA-UHFFFAOYSA-N N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[18-(2,3-dihydroxybutan-2-yl)-11-ethylidene-59-hydroxy-8,31-bis(1-hydroxyethyl)-26,46-dimethyl-40,43-dimethylidene-6,9,16,23,28,38,41,44,47-nonaoxo-37-propan-2-yl-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide Chemical compound N=1C2C(N=3)=CSC=3C(C(C)OC(=O)C=3N=C4C(O)C(NC(C(C)C)C(=O)NC(=C)C(=O)NC(=C)C(=O)NC(C)C(=O)N5)C=CC4=C(C(C)O)C=3)NC(=O)C(N=3)=CSC=3C(C(C)(O)C(C)O)NC(=O)C(N=3)CSC=3C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=3)=CSC=3C25CCC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 AKFVOKPQHFBYCA-UHFFFAOYSA-N 0.000 abstract 1
- 229930190676 Siomycin Natural products 0.000 abstract 1
- 241000194049 Streptococcus equinus Species 0.000 abstract 1
- 101500019191 Streptomyces actuosus Nosiheptide Proteins 0.000 abstract 1
- 101000968300 Streptomyces griseoverticillatus Lantibiotic duramycin Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 229930185202 Thiopeptin Natural products 0.000 abstract 1
- IXEQUEFFDUXSRS-UGJHNBEYSA-N Thiopeptin Bb Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)[C@]34CCC(=N[C@@H]3c5csc(n5)[C@@H](NC(=S)c6csc(n6)[C@H](NC(=O)[C@@H]7CN=C1S7)[C@@](C)(O)[C@H](C)O)[C@H](C)OC(=O)c8cc([C@@H](C)O)c9C=C[C@@H](N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)NC(=C)C(=O)N[C@H](C)C(=O)N4)[C@@H](O)c9n8)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)O)[C@H](C)O IXEQUEFFDUXSRS-UGJHNBEYSA-N 0.000 abstract 1
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 abstract 1
- 108010035783 actinotiocin Proteins 0.000 abstract 1
- HDNVYHWHCVTDIV-AUHWTNQGSA-N amicetin Chemical compound O([C@H]1CC[C@@H](O[C@@H]1C)N1C(N=C(NC(=O)C=2C=CC(NC(=O)C(C)(N)CO)=CC=2)C=C1)=O)[C@H]1O[C@H](C)[C@@H](N(C)C)[C@H](O)[C@H]1O HDNVYHWHCVTDIV-AUHWTNQGSA-N 0.000 abstract 1
- HDNVYHWHCVTDIV-UHFFFAOYSA-N amicetin Natural products CC1OC(N2C(N=C(NC(=O)C=3C=CC(NC(=O)C(C)(N)CO)=CC=3)C=C2)=O)CCC1OC1OC(C)C(N(C)C)C(O)C1O HDNVYHWHCVTDIV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- AKFVOKPQHFBYCA-ASKSIGGCSA-N chembl1967607 Chemical compound N=1C2C(N=3)=CSC=3C(C(C)OC(=O)C=3N=C4C(O)C(NC(C(C)C)C(=O)NC(=C)C(=O)NC(=C)C(=O)NC(C)C(=O)N5)C=CC4=C(C(C)O)C=3)NC(=O)C(N=3)=CSC=3C(C(C)(O)C(C)O)NC(=O)C(N=3)CSC=3C(=C/C)/NC(=O)C(C(C)O)NC(=O)C(N=3)=CSC=3C25CCC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 AKFVOKPQHFBYCA-ASKSIGGCSA-N 0.000 abstract 1
- 210000002249 digestive system Anatomy 0.000 abstract 1
- 239000003651 drinking water Substances 0.000 abstract 1
- 235000020188 drinking water Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 abstract 1
- 108010088584 siomycin Proteins 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 108010087907 sporangiomycin Proteins 0.000 abstract 1
- SRTDKHGZQCTGBY-RVDKCFQWSA-N thiopeptin Chemical compound N1C2C(N=3)=CSC=3C(C(C)OC(=O)C=3N=C4C(O)C(NC(C(C)C)C(=O)NC(C)C(=O)NC(=C)C(=O)NC(C)C(=O)N5)C=CC4=C(C(C)O)C=3)NC(=S)C(N=3)=CSC=3C(C(C)(O)C(C)O)NC(=O)C(N=3)CSC=3C(=C/C)\NC(=O)C(C(C)O)NC(=O)C(N=3)=CSC=3C25CCC1C1=NC(C(N)=O)=CS1 SRTDKHGZQCTGBY-RVDKCFQWSA-N 0.000 abstract 1
- 108010030742 thiopeptin Proteins 0.000 abstract 1
- 229930188070 thiostrepton Natural products 0.000 abstract 1
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 abstract 1
- 229940063214 thiostrepton Drugs 0.000 abstract 1
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44499174A | 1974-02-22 | 1974-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1479496A true GB1479496A (en) | 1977-07-13 |
Family
ID=23767205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB6613/75A Expired GB1479496A (en) | 1974-02-22 | 1975-02-17 | Antibiotic compositions |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS6037091B2 (xx) |
| CA (1) | CA1059910A (xx) |
| DE (1) | DE2507565A1 (xx) |
| FR (1) | FR2261778B1 (xx) |
| GB (1) | GB1479496A (xx) |
| NL (1) | NL7501246A (xx) |
| ZA (1) | ZA751091B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6011012B2 (ja) * | 1975-10-28 | 1985-03-22 | クミアイ化学工業株式会社 | 豚及び家禽用成長促進剤並びに家禽用産卵増進剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3761587A (en) * | 1971-02-23 | 1973-09-25 | Fujisama Pharmaceutical Co Ltd | Antibiotic thiopeptin and process of production |
| US3790668A (en) * | 1972-12-15 | 1974-02-05 | Lilly Co Eli | Ruminant feed utilization improvement |
-
1975
- 1975-02-03 NL NL7501246A patent/NL7501246A/xx not_active Application Discontinuation
- 1975-02-11 CA CA219,858A patent/CA1059910A/en not_active Expired
- 1975-02-17 GB GB6613/75A patent/GB1479496A/en not_active Expired
- 1975-02-20 FR FR7505268A patent/FR2261778B1/fr not_active Expired
- 1975-02-21 DE DE19752507565 patent/DE2507565A1/de not_active Withdrawn
- 1975-02-21 ZA ZA00751091A patent/ZA751091B/xx unknown
- 1975-02-21 JP JP50021064A patent/JPS6037091B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2261778A1 (xx) | 1975-09-19 |
| AU7807775A (en) | 1976-08-12 |
| ZA751091B (en) | 1976-10-27 |
| JPS6037091B2 (ja) | 1985-08-24 |
| NL7501246A (nl) | 1975-08-26 |
| FR2261778B1 (xx) | 1978-07-21 |
| CA1059910A (en) | 1979-08-07 |
| DE2507565A1 (de) | 1975-08-28 |
| JPS50129714A (xx) | 1975-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tally et al. | Metronidazole versus anaerobes—in vitro data and initial clinical observations | |
| EP0456418B1 (en) | Treatment of clostridium difficile diarrhoea and pseudomembranous colitis | |
| IE39095L (en) | Feed additive for ruminants. | |
| IE36022B1 (en) | Rearing of fish | |
| Ben-Efraim et al. | Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth | |
| Kueppers et al. | Effect of total parenteral nutrition plus morphine on bacterial translocation in rats | |
| Lanigan | Metabolism of pyrrolizidine alkaloids in the ovine rumen. II. Some factors affecting rate of alkaloid breakdown by rumen fluid in vitro | |
| GB1360462A (en) | Isoflavone derivative | |
| Barrentine et al. | Antibiotics for the prevention of bloat in cattle grazing Ladino clover | |
| GB1535111A (en) | Treatment of ruminants | |
| GB1479496A (en) | Antibiotic compositions | |
| Mateos et al. | Minimum inhibitory concentrations for selected antimicrobial agents against Fusobacterium necrophorum isolated from hepatic abscesses in cattle and sheep | |
| Haddad et al. | Chicken growth hormone, triiodothyronine and thyrotropin releasing hormone modulation of the levels of chicken natural cell-mediated cytotoxicity | |
| Alvares et al. | Effect of barbituric acid, chlortetracycline and carbohydrates upon growth and gastrointestinal urease activity of chicks | |
| US3692904A (en) | Method for treating scours in domestic livestock | |
| Ilavsky et al. | Observations on antibiotic treatment of bacterial infections of cortisone-treated mice | |
| GB1404614A (en) | Antibiotic a477 and process for preparation thereof | |
| US3488417A (en) | Veterinary preparations having a coating resistant to the rumen contents | |
| Catron et al. | Vitamin B12 Requirement of Weanling Pigs II. Performance on Low Levels of Vitamin B12 and Requirement for Optimum Growth | |
| GB1336015A (en) | Rearing pigs | |
| Herman | Oxytetracycline in Fish Culture:--A Review | |
| KR100375342B1 (ko) | 위장 질환 개선을 위한 천연 항균물질 조성물 | |
| Smith et al. | An Interrelation of Pteroylglutamic Acid, Vitamin B12 and the Monkey Anti-Anemia Factor | |
| Brazle | Effect of medicated mineral mixtures and a pinkeye vaccine on the gain and health of steers grazing native grass pastures | |
| Gbodi et al. | Some observations on chemotherapy of bovine dermatophilosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |